MYC activation contributes to cancer by increasing transcriptional activity (32, 33) through interactions with binding partners such as MAX (27, –29), MAD (30), MNT (31), and MIZ1 (85), to generally as well as selectively modulate the expression of target genes (34, 35). This evidence concerns the gene MAX and cancer.